| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849143 | American Heart Journal | 2007 | 7 Pages |
Abstract
In patients with diabetes who remain symptomatic, the addition of trimetazidine improves symptoms and exercise responses without hemodynamic or metabolic changes. The present data suggest that trimetazidine may be an effective adjunct therapy for these patients, but further investigation is needed to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
LetÃcia Weiss MD, MSc, Jorge P. MD, ScD, Ricardo MD, ScD, Cristiane MD, MSc, CarÃsi Anne MD, ScD,